Oxaprozin Impurity 2(24248-49-5)
- Name: Oxaprozin Impurity 2
- Synonyms:2-Oxazolepropionamide,4,5-diphenyl- (8CI); Wy 22075; b-(4,5-Diphenyloxazol-2-yl)propionamide
- Molecular Formula:C18H16 N2 O2
- Molecular Weight:292.337
- CAS Registry Number:24248-49-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.24248-49-5 Oxaprozin impurity 2
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.24248-49-5 Oxaprozin Impurity 2
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Oxaprozin Impurity 2
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.24248-49-5 Oxaprozin Impurity 2
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.24248-49-5 Oxaprozin Impurity 2
Assay:> 95% Appearance:White Solid Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 79953-86-9/[N,N',N'',N'''-tetrakis[2-(hexadecyloxy)phenyl]-29H,31H-phthalocyaninetetrasulphonamidato(2-)-N29,N30,N31,N32]copper
- 29941-93-3/2-(4-butanoylphenoxy)-2-methylpropanoic acid
- 6325-60-6/1-(1-hydroxynaphthalen-2-yl)-6-phenylhexan-1-one
- 25090-73-7/(1aR,1bS,4aR,7aS,7bR,8R,9aS)-3-[(acetyloxy)methyl]-4a,7b-dihydroxy-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl 2-methylbutanoate
- 36195-33-2/p-formylphenyl methacrylate
- 33547-50-1/(-)-4-(1,2-Dihydroxyethyl)-8-hydroxy-1H-2-benzopyran-1-one
- 6021-45-0/(5Z)-5-({3-methoxy-4-[(5-nitropyridin-2-yl)oxy]phenyl}methylidene)-2-thioxoimidazolidin-4-one
- 1263-63-4/MESOPORPHYRIN IX DIMETHYL ESTER
- 27720-87-2/3-bromo-2,3-dihydro-4H-thiochromen-4-one 1,1-dioxide
- 91045-33-9/3-(1-{1-[(4-methylpiperidin-1-yl)methyl]-1H-benzimidazol-2-yl}-2-phenylethyl)-2-phenylquinazolin-4(3H)-one
- 27961-95-1/5-[(E)-(2-methoxyphenyl)diazenyl]-4-methyl-6-phenylpyrimidin-2-amine
- 6941-20-4/N-cyclohexyl-P,P-diphenylphosphinic amide
- 3691-68-7/sodium N-(5-bromo-4,6-dimethyl-2-pyrimidinyl)sulphanilamidate
- 66654-22-6/alpha-Methyl-1H-indole-3-ethylamine monomethanesulphonate
- 73129-61-0/1-methyl-4-(2-methyl-10,11-dihydrodibenzo[b,f]thiepin-10-yl)piperazine (2E)-but-2-enedioate
- 19490-94-9/1-phenyl-1-(pyridin-4-yl)ethanol
- 59831-96-8/N-cyclopropyl-3-phenylprop-2-enamide
- 104340-41-2/NC-1300-B
- 137052-86-9/4-(3-chlorophenyl)-5,6,8,9-tetrahydro-4H,7H-cyclopenta[4,5]thieno[3,2-f]pyrrolo[1,2-a][1,4]diazepine
- 24248-49-5/Oxaprozin Impurity 2
- 87653-69-8/Acetamide,N-(butoxymethyl)-2-chloro-N-(2,6- diethylphenyl)-,mixt. with (2,4-dichlorophenyl)[1,3-dimethyl-5-[[(4- methylphenyl)sulfonyl]oxy]-1H-pyrazol-4-yl]- methanone
- 20069-08-3/1-(2-Pyrrolizinoethyl)-1,2,3,4-tetrahydro-β-carboline
- 17550-38-8/(1S,6S)-2β,3α-Diacetoxy-1-[(benzoyloxy)methyl]-7-oxabicyclo[4.1.0]hept-4-ene
- 24241-89-2/Phosphoramidic acid,(2,3,5,6-tetrachloro-4-pyridinyl)-, dibutyl ester (9CI)
- 62832-34-2/3-[(1,4-diphenyl-1H-pyrazol-3-yl)oxy]-N,N-dimethylpropan-1-amine hydrochloride
- 66709-63-5/N-butyl-6-undecyl-1,3,5-triazine-2,4-diamine
- 34454-78-9/3-methylbut-2-en-2-ol
- 94530-86-6/Senkyunolide J
- 61541-97-7/1-bromo-4-{[4-(4-methylphenoxy)but-2-en-1-yl]sulfanyl}benzene
- 26369-05-1/1-[3-(5H-dibenzo[b,f]azepin-5-yl)propyl]-4-(4-methylphenyl)piperidin-4-ol hydrochloride (1:1)